CD8A and cancer: Major histocompatibility complex (MHC) class I molecules facilitate the immune recognition of cancer cells, promoting the presentation of small-peptide fragments of non-self antigens on the cell surface, allowing their identification by CD8+ cytotoxic T lymphocytes [118,142,166,167,168,169,170].